Laura C.A. Galbraith

2.0k total citations
17 papers, 657 citations indexed

About

Laura C.A. Galbraith is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Laura C.A. Galbraith has authored 17 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Laura C.A. Galbraith's work include Cancer, Lipids, and Metabolism (6 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Prostate Cancer Treatment and Research (3 papers). Laura C.A. Galbraith is often cited by papers focused on Cancer, Lipids, and Metabolism (6 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Prostate Cancer Treatment and Research (3 papers). Laura C.A. Galbraith collaborates with scholars based in United Kingdom, United States and Canada. Laura C.A. Galbraith's co-authors include Hing Y. Leung, Imran Ahmad, Eyal Gottlieb, Mark J. Salji, Ernest Mui, Franziska Baenke, Asier Unciti‐Broceta, María Romina Girotti, Nathalie Dhomen and Matthew J. Martin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Cell Biology.

In The Last Decade

Laura C.A. Galbraith

15 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura C.A. Galbraith United Kingdom 11 465 239 109 106 68 17 657
Seon-Hyeong Lee South Korea 16 439 0.9× 295 1.2× 87 0.8× 119 1.1× 42 0.6× 29 705
Phuong Nguyen United States 7 532 1.1× 354 1.5× 159 1.5× 129 1.2× 49 0.7× 10 728
Inger Anne Netland Norway 5 334 0.7× 154 0.6× 126 1.2× 117 1.1× 34 0.5× 6 574
Yongik Lee United States 8 520 1.1× 199 0.8× 148 1.4× 210 2.0× 53 0.8× 8 782
Prahlad V. Raninga Australia 15 533 1.1× 115 0.5× 175 1.6× 67 0.6× 71 1.0× 25 742
Go Woon Kim South Korea 17 528 1.1× 126 0.5× 158 1.4× 83 0.8× 44 0.6× 25 716
Erica Pranzini Italy 14 373 0.8× 262 1.1× 107 1.0× 45 0.4× 20 0.3× 31 577
Chenchu Lin United States 11 392 0.8× 178 0.7× 123 1.1× 114 1.1× 16 0.2× 18 627
Edward Stuttfeld Switzerland 9 547 1.2× 120 0.5× 146 1.3× 39 0.4× 37 0.5× 11 743
Pierosandro Tagliaferri Italy 17 627 1.3× 229 1.0× 308 2.8× 91 0.9× 32 0.5× 36 983

Countries citing papers authored by Laura C.A. Galbraith

Since Specialization
Citations

This map shows the geographic impact of Laura C.A. Galbraith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura C.A. Galbraith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura C.A. Galbraith more than expected).

Fields of papers citing papers by Laura C.A. Galbraith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura C.A. Galbraith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura C.A. Galbraith. The network helps show where Laura C.A. Galbraith may publish in the future.

Co-authorship network of co-authors of Laura C.A. Galbraith

This figure shows the co-authorship network connecting the top 25 collaborators of Laura C.A. Galbraith. A scholar is included among the top collaborators of Laura C.A. Galbraith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura C.A. Galbraith. Laura C.A. Galbraith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Galbraith, Laura C.A., Robin Shaw, Rajan Veeratterapillay, et al.. (2025). Loss of ARID1A accelerates prostate tumourigenesis with a proliferative collagen-poor phenotype through co-operation with AP1 subunit cFos. British Journal of Cancer. 132(6). 502–512.
2.
Ackermann, Tobias, Engy Shokry, Laura C.A. Galbraith, et al.. (2024). Breast cancer secretes anti-ferroptotic MUFAs and depends on selenoprotein synthesis for metastasis. EMBO Molecular Medicine. 16(11). 2749–2774. 7 indexed citations
3.
Vaughan, Laurence M., et al.. (2024). Variables that impact HPV test accuracy during vaginal self collection workflow for cervical cancer screening. Gynecologic Oncology Reports. 54. 101421–101421.
4.
Shaw, Robin, et al.. (2023). MBTPS2 acts as a regulator of lipogenesis and cholesterol synthesis through SREBP signalling in prostate cancer. British Journal of Cancer. 128(11). 1991–1999. 8 indexed citations
5.
Sandilands, Emma, Álvaro Román‐Fernández, Lynn McGarry, et al.. (2023). The small GTPase ARF3 controls invasion modality and metastasis by regulating N-cadherin levels. The Journal of Cell Biology. 222(4). 4 indexed citations
6.
Sandilands, Emma, Álvaro Román‐Fernández, Susan Mason, et al.. (2021). An ARF GTPase module promoting invasion and metastasis through regulating phosphoinositide metabolism. Nature Communications. 12(1). 1623–1623. 10 indexed citations
7.
Galbraith, Laura C.A., Ernest Mui, Colin Nixon, et al.. (2021). PPAR-gamma induced AKT3 expression increases levels of mitochondrial biogenesis driving prostate cancer. Oncogene. 40(13). 2355–2366. 43 indexed citations
8.
Mével, Renaud, Susan Mason, Laura C.A. Galbraith, et al.. (2020). RUNX1 marks a luminal castration-resistant lineage established at the onset of prostate development. eLife. 9. 27 indexed citations
9.
Fitzsimmons, Leah, Catherine Chang, Laura C.A. Galbraith, et al.. (2019). EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins. Cell Death and Differentiation. 27(5). 1554–1568. 47 indexed citations
10.
Bray, Thomas L., Mark J. Salji, Alessandro Brombin, et al.. (2018). Bright insights into palladium-triggered local chemotherapy. Chemical Science. 9(37). 7354–7361. 86 indexed citations
11.
Galbraith, Laura C.A., Hing Y. Leung, & Imran Ahmad. (2018). Lipid pathway deregulation in advanced prostate cancer. Pharmacological Research. 131. 177–184. 96 indexed citations
12.
Lu, Ya‐Wen, Laura C.A. Galbraith, Mia L. Pras‐Raves, et al.. (2016). Defining functional classes of Barth syndrome mutation in humans. Human Molecular Genetics. 25(9). 1754–1770. 56 indexed citations
13.
Ahmad, Imran, Ernest Mui, Laura C.A. Galbraith, et al.. (2016). Sleeping Beautyscreen revealsPpargactivation in metastatic prostate cancer. Proceedings of the National Academy of Sciences. 113(29). 8290–8295. 87 indexed citations
14.
Baenke, Franziska, Barbara Chaneton, Matthew Smith, et al.. (2015). Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells. Molecular Oncology. 10(1). 73–84. 131 indexed citations
15.
Schug, Zachary T., Christian Frezza, Laura C.A. Galbraith, & Eyal Gottlieb. (2012). The music of lipids: How lipid composition orchestrates cellular behaviour. Acta Oncologica. 51(3). 301–310. 36 indexed citations
16.
Kemppainen, Esko, Daniel J.M. Fernández‐Ayala, Laura C.A. Galbraith, Kevin M.C. O’Dell, & Howard T. Jacobs. (2009). Phenotypic suppression of the Drosophila mitochondrial disease-like mutant tko25t by duplication of the mutant gene in its natural chromosomal context. Mitochondrion. 9(5). 353–363. 12 indexed citations
17.
Galbraith, Laura C.A., et al.. (1987). Postnatal classes on prevention of sleeplessness in young children. Child Care Health and Development. 13(6). 415–420. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seon-Hyeong Lee Breakdown of academic impact, for papers by Phuong Nguyen Breakdown of academic impact, for papers by Inger Anne Netland Breakdown of academic impact, for papers by Yongik Lee Breakdown of academic impact, for papers by Prahlad V. Raninga Breakdown of academic impact, for papers by Go Woon Kim Breakdown of academic impact, for papers by Erica Pranzini Breakdown of academic impact, for papers by Chenchu Lin Breakdown of academic impact, for papers by Edward Stuttfeld Breakdown of academic impact, for papers by Pierosandro Tagliaferri
Rankless by CCL
2026